Global Equine Rabies Immunoglobulin (ERIG) Market Insights, Forecast to 2029
This report presents an overview of global market for Equine Rabies Immunoglobulin (ERIG), sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Equine Rabies Immunoglobulin (ERIG), also provides the sales of main regions and countries. Highlights of the upcoming market potential for Equine Rabies Immunoglobulin (ERIG), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Equine Rabies Immunoglobulin (ERIG) sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Equine Rabies Immunoglobulin (ERIG) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Equine Rabies Immunoglobulin (ERIG) sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Serum China, Lanzhou Institute of Biological Products, Wuhan Institute of Biological Products, Premium Serums, Haffkine Bio-Pharmaceutical and Bharat Serums, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Equine Rabies Immunoglobulin (ERIG) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Equine Rabies Immunoglobulin (ERIG) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Equine Rabies Immunoglobulin (ERIG) sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
This report researches the key producers of Equine Rabies Immunoglobulin (ERIG), also provides the sales of main regions and countries. Highlights of the upcoming market potential for Equine Rabies Immunoglobulin (ERIG), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Equine Rabies Immunoglobulin (ERIG) sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Equine Rabies Immunoglobulin (ERIG) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Equine Rabies Immunoglobulin (ERIG) sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Serum China, Lanzhou Institute of Biological Products, Wuhan Institute of Biological Products, Premium Serums, Haffkine Bio-Pharmaceutical and Bharat Serums, etc.
By Company
- Serum China
- Lanzhou Institute of Biological Products
- Wuhan Institute of Biological Products
- Premium Serums
- Haffkine Bio-Pharmaceutical
- Bharat Serums
- 1500IU
- 1000IU
- 400IU
- Other
- Category II Exposure
- Category III Exposure
- US & Canada
- U.S.
- Canada
- China
- Asia (excluding China)
- Japan
- South Korea
- China Taiwan
- Southeast Asia
- India
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Middle East, Africa, Latin America
- Brazil
- Mexico
- Turkey
- Israel
- GCC Countries
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Equine Rabies Immunoglobulin (ERIG) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Equine Rabies Immunoglobulin (ERIG) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Equine Rabies Immunoglobulin (ERIG) sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 STUDY COVERAGE
1.1 Equine Rabies Immunoglobulin (ERIG) Product Introduction
1.2 Market by Type
1.2.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 1500IU
1.2.3 1000IU
1.2.4 400IU
1.2.5 Other
1.3 Market by Application
1.3.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Estimates and Forecasts 2018-2029
2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region
2.2.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2018-2023)
2.2.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2024-2029)
2.2.4 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2018-2029)
2.3 Global Equine Rabies Immunoglobulin (ERIG) Sales Estimates and Forecasts 2018-2029
2.4 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region
2.4.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2018-2023)
2.4.3 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2024-2029)
2.4.4 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Manufacturers
3.1.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Manufacturers (2018-2023)
3.1.2 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Equine Rabies Immunoglobulin (ERIG) in 2022
3.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Manufacturers
3.2.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Manufacturers (2018-2023)
3.2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Equine Rabies Immunoglobulin (ERIG) Revenue in 2022
3.3 Global Key Players of Equine Rabies Immunoglobulin (ERIG), Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Equine Rabies Immunoglobulin (ERIG) Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Equine Rabies Immunoglobulin (ERIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Equine Rabies Immunoglobulin (ERIG), Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Equine Rabies Immunoglobulin (ERIG), Product Offered and Application
3.8 Global Key Manufacturers of Equine Rabies Immunoglobulin (ERIG), Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Type
4.1.1 Global Equine Rabies Immunoglobulin (ERIG) Historical Sales by Type (2018-2023)
4.1.2 Global Equine Rabies Immunoglobulin (ERIG) Forecasted Sales by Type (2024-2029)
4.1.3 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2018-2029)
4.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type
4.2.1 Global Equine Rabies Immunoglobulin (ERIG) Historical Revenue by Type (2018-2023)
4.2.2 Global Equine Rabies Immunoglobulin (ERIG) Forecasted Revenue by Type (2024-2029)
4.2.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2018-2029)
4.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Type
4.3.1 Global Equine Rabies Immunoglobulin (ERIG) Price by Type (2018-2023)
4.3.2 Global Equine Rabies Immunoglobulin (ERIG) Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Application
5.1.1 Global Equine Rabies Immunoglobulin (ERIG) Historical Sales by Application (2018-2023)
5.1.2 Global Equine Rabies Immunoglobulin (ERIG) Forecasted Sales by Application (2024-2029)
5.1.3 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2018-2029)
5.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application
5.2.1 Global Equine Rabies Immunoglobulin (ERIG) Historical Revenue by Application (2018-2023)
5.2.2 Global Equine Rabies Immunoglobulin (ERIG) Forecasted Revenue by Application (2024-2029)
5.2.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2018-2029)
5.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Application
5.3.1 Global Equine Rabies Immunoglobulin (ERIG) Price by Application (2018-2023)
5.3.2 Global Equine Rabies Immunoglobulin (ERIG) Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada Equine Rabies Immunoglobulin (ERIG) Market Size by Type
6.1.1 US & Canada Equine Rabies Immunoglobulin (ERIG) Sales by Type (2018-2029)
6.1.2 US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2018-2029)
6.2 US & Canada Equine Rabies Immunoglobulin (ERIG) Market Size by Application
6.2.1 US & Canada Equine Rabies Immunoglobulin (ERIG) Sales by Application (2018-2029)
6.2.2 US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2018-2029)
6.3 US & Canada Equine Rabies Immunoglobulin (ERIG) Market Size by Country
6.3.1 US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Equine Rabies Immunoglobulin (ERIG) Sales by Country (2018-2029)
6.3.3 US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Type
7.1.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2018-2029)
7.1.2 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2018-2029)
7.2 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Application
7.2.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2018-2029)
7.2.2 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2018-2029)
7.3 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Country
7.3.1 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2018-2029)
7.3.3 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China Equine Rabies Immunoglobulin (ERIG) Market Size
8.1.1 China Equine Rabies Immunoglobulin (ERIG) Sales (2018-2029)
8.1.2 China Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029)
8.2 China Equine Rabies Immunoglobulin (ERIG) Market Size by Application
8.2.1 China Equine Rabies Immunoglobulin (ERIG) Sales by Application (2018-2029)
8.2.2 China Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Equine Rabies Immunoglobulin (ERIG) Market Size by Type
9.1.1 Asia Equine Rabies Immunoglobulin (ERIG) Sales by Type (2018-2029)
9.1.2 Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2018-2029)
9.2 Asia Equine Rabies Immunoglobulin (ERIG) Market Size by Application
9.2.1 Asia Equine Rabies Immunoglobulin (ERIG) Sales by Application (2018-2029)
9.2.2 Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2018-2029)
9.3 Asia Equine Rabies Immunoglobulin (ERIG) Sales by Region
9.3.1 Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2018-2029)
9.3.3 Asia Equine Rabies Immunoglobulin (ERIG) Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Market Size by Type
10.1.1 Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Market Size by Application
10.2.1 Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country
10.3.1 Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 Serum China
11.1.1 Serum China Company Information
11.1.2 Serum China Overview
11.1.3 Serum China Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Serum China Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Serum China Recent Developments
11.2 Lanzhou Institute of Biological Products
11.2.1 Lanzhou Institute of Biological Products Company Information
11.2.2 Lanzhou Institute of Biological Products Overview
11.2.3 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Lanzhou Institute of Biological Products Recent Developments
11.3 Wuhan Institute of Biological Products
11.3.1 Wuhan Institute of Biological Products Company Information
11.3.2 Wuhan Institute of Biological Products Overview
11.3.3 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Wuhan Institute of Biological Products Recent Developments
11.4 Premium Serums
11.4.1 Premium Serums Company Information
11.4.2 Premium Serums Overview
11.4.3 Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Premium Serums Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Premium Serums Recent Developments
11.5 Haffkine Bio-Pharmaceutical
11.5.1 Haffkine Bio-Pharmaceutical Company Information
11.5.2 Haffkine Bio-Pharmaceutical Overview
11.5.3 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Haffkine Bio-Pharmaceutical Recent Developments
11.6 Bharat Serums
11.6.1 Bharat Serums Company Information
11.6.2 Bharat Serums Overview
11.6.3 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bharat Serums Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Equine Rabies Immunoglobulin (ERIG) Industry Chain Analysis
12.2 Equine Rabies Immunoglobulin (ERIG) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Equine Rabies Immunoglobulin (ERIG) Production Mode & Process
12.4 Equine Rabies Immunoglobulin (ERIG) Sales and Marketing
12.4.1 Equine Rabies Immunoglobulin (ERIG) Sales Channels
12.4.2 Equine Rabies Immunoglobulin (ERIG) Distributors
12.5 Equine Rabies Immunoglobulin (ERIG) Customers
13 MARKET DYNAMICS
13.1 Equine Rabies Immunoglobulin (ERIG) Industry Trends
13.2 Equine Rabies Immunoglobulin (ERIG) Market Drivers
13.3 Equine Rabies Immunoglobulin (ERIG) Market Challenges
13.4 Equine Rabies Immunoglobulin (ERIG) Market Restraints
14 KEY FINDINGS IN THE GLOBAL EQUINE RABIES IMMUNOGLOBULIN (ERIG) STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Equine Rabies Immunoglobulin (ERIG) Product Introduction
1.2 Market by Type
1.2.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 1500IU
1.2.3 1000IU
1.2.4 400IU
1.2.5 Other
1.3 Market by Application
1.3.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Estimates and Forecasts 2018-2029
2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region
2.2.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2018-2023)
2.2.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2024-2029)
2.2.4 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2018-2029)
2.3 Global Equine Rabies Immunoglobulin (ERIG) Sales Estimates and Forecasts 2018-2029
2.4 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region
2.4.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2018-2023)
2.4.3 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2024-2029)
2.4.4 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Manufacturers
3.1.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Manufacturers (2018-2023)
3.1.2 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Equine Rabies Immunoglobulin (ERIG) in 2022
3.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Manufacturers
3.2.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Manufacturers (2018-2023)
3.2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Equine Rabies Immunoglobulin (ERIG) Revenue in 2022
3.3 Global Key Players of Equine Rabies Immunoglobulin (ERIG), Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Equine Rabies Immunoglobulin (ERIG) Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Equine Rabies Immunoglobulin (ERIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Equine Rabies Immunoglobulin (ERIG), Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Equine Rabies Immunoglobulin (ERIG), Product Offered and Application
3.8 Global Key Manufacturers of Equine Rabies Immunoglobulin (ERIG), Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Type
4.1.1 Global Equine Rabies Immunoglobulin (ERIG) Historical Sales by Type (2018-2023)
4.1.2 Global Equine Rabies Immunoglobulin (ERIG) Forecasted Sales by Type (2024-2029)
4.1.3 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2018-2029)
4.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type
4.2.1 Global Equine Rabies Immunoglobulin (ERIG) Historical Revenue by Type (2018-2023)
4.2.2 Global Equine Rabies Immunoglobulin (ERIG) Forecasted Revenue by Type (2024-2029)
4.2.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2018-2029)
4.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Type
4.3.1 Global Equine Rabies Immunoglobulin (ERIG) Price by Type (2018-2023)
4.3.2 Global Equine Rabies Immunoglobulin (ERIG) Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Application
5.1.1 Global Equine Rabies Immunoglobulin (ERIG) Historical Sales by Application (2018-2023)
5.1.2 Global Equine Rabies Immunoglobulin (ERIG) Forecasted Sales by Application (2024-2029)
5.1.3 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2018-2029)
5.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application
5.2.1 Global Equine Rabies Immunoglobulin (ERIG) Historical Revenue by Application (2018-2023)
5.2.2 Global Equine Rabies Immunoglobulin (ERIG) Forecasted Revenue by Application (2024-2029)
5.2.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2018-2029)
5.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Application
5.3.1 Global Equine Rabies Immunoglobulin (ERIG) Price by Application (2018-2023)
5.3.2 Global Equine Rabies Immunoglobulin (ERIG) Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada Equine Rabies Immunoglobulin (ERIG) Market Size by Type
6.1.1 US & Canada Equine Rabies Immunoglobulin (ERIG) Sales by Type (2018-2029)
6.1.2 US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2018-2029)
6.2 US & Canada Equine Rabies Immunoglobulin (ERIG) Market Size by Application
6.2.1 US & Canada Equine Rabies Immunoglobulin (ERIG) Sales by Application (2018-2029)
6.2.2 US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2018-2029)
6.3 US & Canada Equine Rabies Immunoglobulin (ERIG) Market Size by Country
6.3.1 US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Equine Rabies Immunoglobulin (ERIG) Sales by Country (2018-2029)
6.3.3 US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Type
7.1.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2018-2029)
7.1.2 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2018-2029)
7.2 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Application
7.2.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2018-2029)
7.2.2 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2018-2029)
7.3 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Country
7.3.1 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2018-2029)
7.3.3 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China Equine Rabies Immunoglobulin (ERIG) Market Size
8.1.1 China Equine Rabies Immunoglobulin (ERIG) Sales (2018-2029)
8.1.2 China Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029)
8.2 China Equine Rabies Immunoglobulin (ERIG) Market Size by Application
8.2.1 China Equine Rabies Immunoglobulin (ERIG) Sales by Application (2018-2029)
8.2.2 China Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Equine Rabies Immunoglobulin (ERIG) Market Size by Type
9.1.1 Asia Equine Rabies Immunoglobulin (ERIG) Sales by Type (2018-2029)
9.1.2 Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2018-2029)
9.2 Asia Equine Rabies Immunoglobulin (ERIG) Market Size by Application
9.2.1 Asia Equine Rabies Immunoglobulin (ERIG) Sales by Application (2018-2029)
9.2.2 Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2018-2029)
9.3 Asia Equine Rabies Immunoglobulin (ERIG) Sales by Region
9.3.1 Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2018-2029)
9.3.3 Asia Equine Rabies Immunoglobulin (ERIG) Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Market Size by Type
10.1.1 Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Market Size by Application
10.2.1 Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country
10.3.1 Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 Serum China
11.1.1 Serum China Company Information
11.1.2 Serum China Overview
11.1.3 Serum China Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Serum China Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Serum China Recent Developments
11.2 Lanzhou Institute of Biological Products
11.2.1 Lanzhou Institute of Biological Products Company Information
11.2.2 Lanzhou Institute of Biological Products Overview
11.2.3 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Lanzhou Institute of Biological Products Recent Developments
11.3 Wuhan Institute of Biological Products
11.3.1 Wuhan Institute of Biological Products Company Information
11.3.2 Wuhan Institute of Biological Products Overview
11.3.3 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Wuhan Institute of Biological Products Recent Developments
11.4 Premium Serums
11.4.1 Premium Serums Company Information
11.4.2 Premium Serums Overview
11.4.3 Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Premium Serums Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Premium Serums Recent Developments
11.5 Haffkine Bio-Pharmaceutical
11.5.1 Haffkine Bio-Pharmaceutical Company Information
11.5.2 Haffkine Bio-Pharmaceutical Overview
11.5.3 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Haffkine Bio-Pharmaceutical Recent Developments
11.6 Bharat Serums
11.6.1 Bharat Serums Company Information
11.6.2 Bharat Serums Overview
11.6.3 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bharat Serums Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Equine Rabies Immunoglobulin (ERIG) Industry Chain Analysis
12.2 Equine Rabies Immunoglobulin (ERIG) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Equine Rabies Immunoglobulin (ERIG) Production Mode & Process
12.4 Equine Rabies Immunoglobulin (ERIG) Sales and Marketing
12.4.1 Equine Rabies Immunoglobulin (ERIG) Sales Channels
12.4.2 Equine Rabies Immunoglobulin (ERIG) Distributors
12.5 Equine Rabies Immunoglobulin (ERIG) Customers
13 MARKET DYNAMICS
13.1 Equine Rabies Immunoglobulin (ERIG) Industry Trends
13.2 Equine Rabies Immunoglobulin (ERIG) Market Drivers
13.3 Equine Rabies Immunoglobulin (ERIG) Market Challenges
13.4 Equine Rabies Immunoglobulin (ERIG) Market Restraints
14 KEY FINDINGS IN THE GLOBAL EQUINE RABIES IMMUNOGLOBULIN (ERIG) STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES
Table 1. Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 1500IU
Table 3. Major Manufacturers of 1000IU
Table 4. Major Manufacturers of 400IU
Table 5. Major Manufacturers of Other
Table 6. Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2018-2023)
Table 11. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2024-2029)
Table 12. Global Equine Rabies Immunoglobulin (ERIG) Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2018-2023) & (Kiloton)
Table 14. Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2024-2029) & (Kiloton)
Table 15. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2018-2023)
Table 16. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2024-2029)
Table 17. Global Equine Rabies Immunoglobulin (ERIG) Sales by Manufacturers (2018-2023) & (Kiloton)
Table 18. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Manufacturers (2018-2023)
Table 19. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Manufacturers (2018-2023)
Table 21. Global Key Players of Equine Rabies Immunoglobulin (ERIG), Industry Ranking, 2021 VS 2022 VS 2023
Table 22. Equine Rabies Immunoglobulin (ERIG) Price by Manufacturers 2018-2023 (US$/Ton)
Table 23. Global Equine Rabies Immunoglobulin (ERIG) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Equine Rabies Immunoglobulin (ERIG) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Rabies Immunoglobulin (ERIG) as of 2022)
Table 25. Global Key Manufacturers of Equine Rabies Immunoglobulin (ERIG), Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Equine Rabies Immunoglobulin (ERIG), Product Offered and Application
Table 27. Global Key Manufacturers of Equine Rabies Immunoglobulin (ERIG), Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2018-2023) & (Kiloton)
Table 30. Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2024-2029) & (Kiloton)
Table 31. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Type (2018-2023)
Table 32. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Type (2024-2029)
Table 33. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Type (2018-2023)
Table 36. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Type (2024-2029)
Table 37. Equine Rabies Immunoglobulin (ERIG) Price by Type (2018-2023) & (US$/Ton)
Table 38. Global Equine Rabies Immunoglobulin (ERIG) Price Forecast by Type (2024-2029) & (US$/Ton)
Table 39. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2018-2023) & (Kiloton)
Table 40. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2024-2029) & (Kiloton)
Table 41. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Application (2018-2023)
Table 42. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Application (2024-2029)
Table 43. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Application (2018-2023)
Table 46. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Application (2024-2029)
Table 47. Equine Rabies Immunoglobulin (ERIG) Price by Application (2018-2023) & (US$/Ton)
Table 48. Global Equine Rabies Immunoglobulin (ERIG) Price Forecast by Application (2024-2029) & (US$/Ton)
Table 49. US & Canada Equine Rabies Immunoglobulin (ERIG) Sales by Type (2018-2023) & (Kiloton)
Table 50. US & Canada Equine Rabies Immunoglobulin (ERIG) Sales by Type (2024-2029) & (Kiloton)
Table 51. US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2018-2023) & (US$ Million)
Table 52. US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Equine Rabies Immunoglobulin (ERIG) Sales by Application (2018-2023) & (Kiloton)
Table 54. US & Canada Equine Rabies Immunoglobulin (ERIG) Sales by Application (2024-2029) & (Kiloton)
Table 55. US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2018-2023) & (US$ Million)
Table 56. US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2018-2023) & (US$ Million)
Table 59. US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Equine Rabies Immunoglobulin (ERIG) Sales by Country (2018-2023) & (Kiloton)
Table 61. US & Canada Equine Rabies Immunoglobulin (ERIG) Sales by Country (2024-2029) & (Kiloton)
Table 62. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2018-2023) & (Kiloton)
Table 63. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2024-2029) & (Kiloton)
Table 64. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2018-2023) & (US$ Million)
Table 65. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2018-2023) & (Kiloton)
Table 67. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2024-2029) & (Kiloton)
Table 68. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2018-2023) & (US$ Million)
Table 69. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2018-2023) & (US$ Million)
Table 72. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2018-2023) & (Kiloton)
Table 74. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2024-2029) & (Kiloton)
Table 75. China Equine Rabies Immunoglobulin (ERIG) Sales by Type (2018-2023) & (Kiloton)
Table 76. China Equine Rabies Immunoglobulin (ERIG) Sales by Type (2024-2029) & (Kiloton)
Table 77. China Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2018-2023) & (US$ Million)
Table 78. China Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Equine Rabies Immunoglobulin (ERIG) Sales by Application (2018-2023) & (Kiloton)
Table 80. China Equine Rabies Immunoglobulin (ERIG) Sales by Application (2024-2029) & (Kiloton)
Table 81. China Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2018-2023) & (US$ Million)
Table 82. China Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Equine Rabies Immunoglobulin (ERIG) Sales by Type (2018-2023) & (Kiloton)
Table 84. Asia Equine Rabies Immunoglobulin (ERIG) Sales by Type (2024-2029) & (Kiloton)
Table 85. Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2018-2023) & (US$ Million)
Table 86. Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Equine Rabies Immunoglobulin (ERIG) Sales by Application (2018-2023) & (Kiloton)
Table 88. Asia Equine Rabies Immunoglobulin (ERIG) Sales by Application (2024-2029) & (Kiloton)
Table 89. Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2018-2023) & (US$ Million)
Table 90. Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2018-2023) & (US$ Million)
Table 93. Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Equine Rabies Immunoglobulin (ERIG) Sales by Region (2018-2023) & (Kiloton)
Table 95. Asia Equine Rabies Immunoglobulin (ERIG) Sales by Region (2024-2029) & (Kiloton)
Table 96. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2018-2023) & (Kiloton)
Table 97. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2024-2029) & (Kiloton)
Table 98. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2018-2023) & (US$ Million)
Table 99. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2018-2023) & (Kiloton)
Table 101. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2024-2029) & (Kiloton)
Table 102. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2018-2023) & (US$ Million)
Table 103. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2018-2023) & (Kiloton)
Table 108. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2024-2029) & (Kiloton)
Table 109. Serum China Company Information
Table 110. Serum China Description and Major Businesses
Table 111. Serum China Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 112. Serum China Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Serum China Recent Developments
Table 114. Lanzhou Institute of Biological Products Company Information
Table 115. Lanzhou Institute of Biological Products Description and Major Businesses
Table 116. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 117. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Lanzhou Institute of Biological Products Recent Developments
Table 119. Wuhan Institute of Biological Products Company Information
Table 120. Wuhan Institute of Biological Products Description and Major Businesses
Table 121. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 122. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Wuhan Institute of Biological Products Recent Developments
Table 124. Premium Serums Company Information
Table 125. Premium Serums Description and Major Businesses
Table 126. Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 127. Premium Serums Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Premium Serums Recent Developments
Table 129. Haffkine Bio-Pharmaceutical Company Information
Table 130. Haffkine Bio-Pharmaceutical Description and Major Businesses
Table 131. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 132. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Haffkine Bio-Pharmaceutical Recent Developments
Table 134. Bharat Serums Company Information
Table 135. Bharat Serums Description and Major Businesses
Table 136. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 137. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Bharat Serums Recent Developments
Table 139. Key Raw Materials Lists
Table 140. Raw Materials Key Suppliers Lists
Table 141. Equine Rabies Immunoglobulin (ERIG) Distributors List
Table 142. Equine Rabies Immunoglobulin (ERIG) Customers List
Table 143. Equine Rabies Immunoglobulin (ERIG) Market Trends
Table 144. Equine Rabies Immunoglobulin (ERIG) Market Drivers
Table 145. Equine Rabies Immunoglobulin (ERIG) Market Challenges
Table 146. Equine Rabies Immunoglobulin (ERIG) Market Restraints
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 1. Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 1500IU
Table 3. Major Manufacturers of 1000IU
Table 4. Major Manufacturers of 400IU
Table 5. Major Manufacturers of Other
Table 6. Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2018-2023)
Table 11. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2024-2029)
Table 12. Global Equine Rabies Immunoglobulin (ERIG) Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2018-2023) & (Kiloton)
Table 14. Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2024-2029) & (Kiloton)
Table 15. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2018-2023)
Table 16. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2024-2029)
Table 17. Global Equine Rabies Immunoglobulin (ERIG) Sales by Manufacturers (2018-2023) & (Kiloton)
Table 18. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Manufacturers (2018-2023)
Table 19. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Manufacturers (2018-2023)
Table 21. Global Key Players of Equine Rabies Immunoglobulin (ERIG), Industry Ranking, 2021 VS 2022 VS 2023
Table 22. Equine Rabies Immunoglobulin (ERIG) Price by Manufacturers 2018-2023 (US$/Ton)
Table 23. Global Equine Rabies Immunoglobulin (ERIG) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Equine Rabies Immunoglobulin (ERIG) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Rabies Immunoglobulin (ERIG) as of 2022)
Table 25. Global Key Manufacturers of Equine Rabies Immunoglobulin (ERIG), Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Equine Rabies Immunoglobulin (ERIG), Product Offered and Application
Table 27. Global Key Manufacturers of Equine Rabies Immunoglobulin (ERIG), Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2018-2023) & (Kiloton)
Table 30. Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2024-2029) & (Kiloton)
Table 31. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Type (2018-2023)
Table 32. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Type (2024-2029)
Table 33. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Type (2018-2023)
Table 36. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Type (2024-2029)
Table 37. Equine Rabies Immunoglobulin (ERIG) Price by Type (2018-2023) & (US$/Ton)
Table 38. Global Equine Rabies Immunoglobulin (ERIG) Price Forecast by Type (2024-2029) & (US$/Ton)
Table 39. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2018-2023) & (Kiloton)
Table 40. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2024-2029) & (Kiloton)
Table 41. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Application (2018-2023)
Table 42. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Application (2024-2029)
Table 43. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Application (2018-2023)
Table 46. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Application (2024-2029)
Table 47. Equine Rabies Immunoglobulin (ERIG) Price by Application (2018-2023) & (US$/Ton)
Table 48. Global Equine Rabies Immunoglobulin (ERIG) Price Forecast by Application (2024-2029) & (US$/Ton)
Table 49. US & Canada Equine Rabies Immunoglobulin (ERIG) Sales by Type (2018-2023) & (Kiloton)
Table 50. US & Canada Equine Rabies Immunoglobulin (ERIG) Sales by Type (2024-2029) & (Kiloton)
Table 51. US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2018-2023) & (US$ Million)
Table 52. US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Equine Rabies Immunoglobulin (ERIG) Sales by Application (2018-2023) & (Kiloton)
Table 54. US & Canada Equine Rabies Immunoglobulin (ERIG) Sales by Application (2024-2029) & (Kiloton)
Table 55. US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2018-2023) & (US$ Million)
Table 56. US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2018-2023) & (US$ Million)
Table 59. US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Equine Rabies Immunoglobulin (ERIG) Sales by Country (2018-2023) & (Kiloton)
Table 61. US & Canada Equine Rabies Immunoglobulin (ERIG) Sales by Country (2024-2029) & (Kiloton)
Table 62. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2018-2023) & (Kiloton)
Table 63. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2024-2029) & (Kiloton)
Table 64. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2018-2023) & (US$ Million)
Table 65. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2018-2023) & (Kiloton)
Table 67. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2024-2029) & (Kiloton)
Table 68. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2018-2023) & (US$ Million)
Table 69. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2018-2023) & (US$ Million)
Table 72. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2018-2023) & (Kiloton)
Table 74. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2024-2029) & (Kiloton)
Table 75. China Equine Rabies Immunoglobulin (ERIG) Sales by Type (2018-2023) & (Kiloton)
Table 76. China Equine Rabies Immunoglobulin (ERIG) Sales by Type (2024-2029) & (Kiloton)
Table 77. China Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2018-2023) & (US$ Million)
Table 78. China Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Equine Rabies Immunoglobulin (ERIG) Sales by Application (2018-2023) & (Kiloton)
Table 80. China Equine Rabies Immunoglobulin (ERIG) Sales by Application (2024-2029) & (Kiloton)
Table 81. China Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2018-2023) & (US$ Million)
Table 82. China Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Equine Rabies Immunoglobulin (ERIG) Sales by Type (2018-2023) & (Kiloton)
Table 84. Asia Equine Rabies Immunoglobulin (ERIG) Sales by Type (2024-2029) & (Kiloton)
Table 85. Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2018-2023) & (US$ Million)
Table 86. Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Equine Rabies Immunoglobulin (ERIG) Sales by Application (2018-2023) & (Kiloton)
Table 88. Asia Equine Rabies Immunoglobulin (ERIG) Sales by Application (2024-2029) & (Kiloton)
Table 89. Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2018-2023) & (US$ Million)
Table 90. Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2018-2023) & (US$ Million)
Table 93. Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Equine Rabies Immunoglobulin (ERIG) Sales by Region (2018-2023) & (Kiloton)
Table 95. Asia Equine Rabies Immunoglobulin (ERIG) Sales by Region (2024-2029) & (Kiloton)
Table 96. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2018-2023) & (Kiloton)
Table 97. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2024-2029) & (Kiloton)
Table 98. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2018-2023) & (US$ Million)
Table 99. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2018-2023) & (Kiloton)
Table 101. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2024-2029) & (Kiloton)
Table 102. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2018-2023) & (US$ Million)
Table 103. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2018-2023) & (Kiloton)
Table 108. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2024-2029) & (Kiloton)
Table 109. Serum China Company Information
Table 110. Serum China Description and Major Businesses
Table 111. Serum China Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 112. Serum China Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Serum China Recent Developments
Table 114. Lanzhou Institute of Biological Products Company Information
Table 115. Lanzhou Institute of Biological Products Description and Major Businesses
Table 116. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 117. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Lanzhou Institute of Biological Products Recent Developments
Table 119. Wuhan Institute of Biological Products Company Information
Table 120. Wuhan Institute of Biological Products Description and Major Businesses
Table 121. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 122. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Wuhan Institute of Biological Products Recent Developments
Table 124. Premium Serums Company Information
Table 125. Premium Serums Description and Major Businesses
Table 126. Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 127. Premium Serums Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Premium Serums Recent Developments
Table 129. Haffkine Bio-Pharmaceutical Company Information
Table 130. Haffkine Bio-Pharmaceutical Description and Major Businesses
Table 131. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 132. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Haffkine Bio-Pharmaceutical Recent Developments
Table 134. Bharat Serums Company Information
Table 135. Bharat Serums Description and Major Businesses
Table 136. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 137. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Bharat Serums Recent Developments
Table 139. Key Raw Materials Lists
Table 140. Raw Materials Key Suppliers Lists
Table 141. Equine Rabies Immunoglobulin (ERIG) Distributors List
Table 142. Equine Rabies Immunoglobulin (ERIG) Customers List
Table 143. Equine Rabies Immunoglobulin (ERIG) Market Trends
Table 144. Equine Rabies Immunoglobulin (ERIG) Market Drivers
Table 145. Equine Rabies Immunoglobulin (ERIG) Market Challenges
Table 146. Equine Rabies Immunoglobulin (ERIG) Market Restraints
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Equine Rabies Immunoglobulin (ERIG) Product Picture
Figure 2. Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Equine Rabies Immunoglobulin (ERIG) Market Share by Type in 2022 & 2029
Figure 4. 1500IU Product Picture
Figure 5. 1000IU Product Picture
Figure 6. 400IU Product Picture
Figure 7. Other Product Picture
Figure 8. Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Equine Rabies Immunoglobulin (ERIG) Market Share by Application in 2022 & 2029
Figure 10. Category II Exposure
Figure 11. Category III Exposure
Figure 12. Equine Rabies Immunoglobulin (ERIG) Report Years Considered
Figure 13. Global Equine Rabies Immunoglobulin (ERIG) Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Equine Rabies Immunoglobulin (ERIG) Revenue 2018-2029 (US$ Million)
Figure 15. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2018-2029)
Figure 17. Global Equine Rabies Immunoglobulin (ERIG) Sales 2018-2029 ((Kiloton)
Figure 18. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Equine Rabies Immunoglobulin (ERIG) Sales YoY (2018-2029) & (Kiloton)
Figure 20. US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Equine Rabies Immunoglobulin (ERIG) Sales YoY (2018-2029) & (Kiloton)
Figure 22. Europe Equine Rabies Immunoglobulin (ERIG) Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Equine Rabies Immunoglobulin (ERIG) Sales YoY (2018-2029) & (Kiloton)
Figure 24. China Equine Rabies Immunoglobulin (ERIG) Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Equine Rabies Immunoglobulin (ERIG) Sales YoY (2018-2029) & (Kiloton)
Figure 26. Asia (excluding China) Equine Rabies Immunoglobulin (ERIG) Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales YoY (2018-2029) & (Kiloton)
Figure 28. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Equine Rabies Immunoglobulin (ERIG) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Equine Rabies Immunoglobulin (ERIG) in the World: Market Share by Equine Rabies Immunoglobulin (ERIG) Revenue in 2022
Figure 31. Global Equine Rabies Immunoglobulin (ERIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2018-2029)
Figure 33. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2018-2029)
Figure 34. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2018-2029)
Figure 35. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue Share by Country (2018-2029)
Figure 41. US & Canada Equine Rabies Immunoglobulin (ERIG) Sales Share by Country (2018-2029)
Figure 42. U.S. Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2018-2029)
Figure 45. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2018-2029)
Figure 46. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2018-2029)
Figure 47. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2018-2029)
Figure 48. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Share by Country (2018-2029)
Figure 49. Europe Equine Rabies Immunoglobulin (ERIG) Sales Share by Country (2018-2029)
Figure 50. Germany Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 51. France Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 55. China Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2018-2029)
Figure 56. China Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2018-2029)
Figure 57. China Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2018-2029)
Figure 58. China Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2018-2029)
Figure 59. Asia Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2018-2029)
Figure 60. Asia Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2018-2029)
Figure 61. Asia Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2018-2029)
Figure 62. Asia Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2018-2029)
Figure 63. Asia Equine Rabies Immunoglobulin (ERIG) Revenue Share by Region (2018-2029)
Figure 64. Asia Equine Rabies Immunoglobulin (ERIG) Sales Share by Region (2018-2029)
Figure 65. Japan Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 69. India Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales Share by Country (2018-2029)
Figure 76. Brazil Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 81. Equine Rabies Immunoglobulin (ERIG) Value Chain
Figure 82. Equine Rabies Immunoglobulin (ERIG) Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
Figure 1. Equine Rabies Immunoglobulin (ERIG) Product Picture
Figure 2. Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Equine Rabies Immunoglobulin (ERIG) Market Share by Type in 2022 & 2029
Figure 4. 1500IU Product Picture
Figure 5. 1000IU Product Picture
Figure 6. 400IU Product Picture
Figure 7. Other Product Picture
Figure 8. Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Equine Rabies Immunoglobulin (ERIG) Market Share by Application in 2022 & 2029
Figure 10. Category II Exposure
Figure 11. Category III Exposure
Figure 12. Equine Rabies Immunoglobulin (ERIG) Report Years Considered
Figure 13. Global Equine Rabies Immunoglobulin (ERIG) Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Equine Rabies Immunoglobulin (ERIG) Revenue 2018-2029 (US$ Million)
Figure 15. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2018-2029)
Figure 17. Global Equine Rabies Immunoglobulin (ERIG) Sales 2018-2029 ((Kiloton)
Figure 18. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Equine Rabies Immunoglobulin (ERIG) Sales YoY (2018-2029) & (Kiloton)
Figure 20. US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Equine Rabies Immunoglobulin (ERIG) Sales YoY (2018-2029) & (Kiloton)
Figure 22. Europe Equine Rabies Immunoglobulin (ERIG) Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Equine Rabies Immunoglobulin (ERIG) Sales YoY (2018-2029) & (Kiloton)
Figure 24. China Equine Rabies Immunoglobulin (ERIG) Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Equine Rabies Immunoglobulin (ERIG) Sales YoY (2018-2029) & (Kiloton)
Figure 26. Asia (excluding China) Equine Rabies Immunoglobulin (ERIG) Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales YoY (2018-2029) & (Kiloton)
Figure 28. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Equine Rabies Immunoglobulin (ERIG) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Equine Rabies Immunoglobulin (ERIG) in the World: Market Share by Equine Rabies Immunoglobulin (ERIG) Revenue in 2022
Figure 31. Global Equine Rabies Immunoglobulin (ERIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2018-2029)
Figure 33. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2018-2029)
Figure 34. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2018-2029)
Figure 35. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Equine Rabies Immunoglobulin (ERIG) Revenue Share by Country (2018-2029)
Figure 41. US & Canada Equine Rabies Immunoglobulin (ERIG) Sales Share by Country (2018-2029)
Figure 42. U.S. Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2018-2029)
Figure 45. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2018-2029)
Figure 46. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2018-2029)
Figure 47. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2018-2029)
Figure 48. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Share by Country (2018-2029)
Figure 49. Europe Equine Rabies Immunoglobulin (ERIG) Sales Share by Country (2018-2029)
Figure 50. Germany Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 51. France Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 55. China Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2018-2029)
Figure 56. China Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2018-2029)
Figure 57. China Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2018-2029)
Figure 58. China Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2018-2029)
Figure 59. Asia Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2018-2029)
Figure 60. Asia Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2018-2029)
Figure 61. Asia Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2018-2029)
Figure 62. Asia Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2018-2029)
Figure 63. Asia Equine Rabies Immunoglobulin (ERIG) Revenue Share by Region (2018-2029)
Figure 64. Asia Equine Rabies Immunoglobulin (ERIG) Sales Share by Region (2018-2029)
Figure 65. Japan Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 69. India Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Equine Rabies Immunoglobulin (ERIG) Sales Share by Country (2018-2029)
Figure 76. Brazil Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Equine Rabies Immunoglobulin (ERIG) Revenue (2018-2029) & (US$ Million)
Figure 81. Equine Rabies Immunoglobulin (ERIG) Value Chain
Figure 82. Equine Rabies Immunoglobulin (ERIG) Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
